Tapeworm drug heading into coronavirus human trials, company says
Silicon Valley-based biotech start-up ANA Therapeutics announced Tuesday that the Food and Drug Administration approved its application for tapeworm drug niclosamide as a potential treatment in COVID-19 and will soon begin human clinical trials.
via FOX NEWS https://ift.tt/3kdgoeX
No comments:
Post a Comment
Thanks for your comment reply within 24 hours